• JACC
  • NCDR
  • Cardiosmart

Society for Cardiovascular Angiography and Interventions

SCAI 2011 | May 4-7, 2011

SCAI 2011
Note that some of these links take you to a site outside of CardioSource.
CardioSource does not assume responsibility for content of external sites.

Saturday May 7 2011

  • Stenting OK for Deep Vein Thrombosis

    BALTIMORE — Stenting is safe and more effective than balloon venoplasty alone for patients with deep vein thrombosis in the femoropopliteal vein, a randomized trial showed.

  • Alcohol Septal Ablation May Be on Par with Myectomy

    BALTIMORE — Percutaneous alcohol septal ablation appears to be as safe as isolated septal myectomy for patients with hypertrophic obstructive cardiomyopathy, across clinical settings and regardless of patient volume, a database study showed.

  • Everolimus-Eluting Stent May Lessen Thrombosis Risk

    BALTIMORE — The second-generation everolimus-eluting stent (Xience V) appears to carry a lower risk of stent thrombosis than first-generation drug-eluting stents, a meta-analysis showed.

Friday May 6 2011

  • Early Detection Trial Hampered by Low MI Rates

    BALTIMORE — There was no correlation found between changes in intracardiac electrograms and spontaneous coronary events in patients with implantable cardioverter-defibrillators (ICDs), although there were substantially fewer events than anticipated, researchers found.

  • Readmits for PCI Complications Near Zero

    BALTIMORE — Very few of the readmissions within 30 days of a percutaneous coronary intervention (PCI) can be tracked back to the procedure itself, data from a single healthcare system showed.

  • Renal Artery Stenting Works, but Biomarker Fails

    BALTIMORE — Measuring brain natriuretic peptide (BNP) levels does not look like a strategy that will work for predicting which patients with renal artery stenosis will respond to stenting, the HERCULES trial showed.

Thursday May 5 2011

  • Carotid Stenting Works in Real World

    BALTIMORE — The carotid stenting results seen in clinical trials can be achieved at the community level, if the effort is there, researchers found.

  • Quality of Life Boost Seen With TAVI

    BALTIMORE — Based on relatively limited data, transcatheter aortic valve implantation (TAVI) appears to improve quality of life in patients with severe aortic stenosis, researchers found.

Advertisement
Advertisement